| 1Sulfanilamide |
|---|
| 2Sulfadiazine |
| 3Sulfamerazine |
| 4Sulfamethoxazole |
| 5Sulfaquinoxaline |
| 6Sulfasalazine |
Compound Name Sulfanilamide |
CID 5333 |
Molecular Formula C6H8N2O2S |
Molecular Weight 172 |
No. Hydrogen Bond Acceptors 4 |
No. Hydrogen Bond Donors 2 |
Applications
Sulfa Drugs on Onyx C18
15504
Separation Mode: Reversed Phase
Reversed Phase
Monolithic C18
HPLC
Antirheumatic Agents
Pharmaceutical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 15504)
Column: | ||||||||||||
Brand Name: | ||||||||||||
Part No: | ||||||||||||
Phase Name: Monolithic C18 | ||||||||||||
Elution Type: Gradient | ||||||||||||
Mobile Phase: A: 0.1%TFA in Water B: ACN | ||||||||||||
Gradient Profile:
| ||||||||||||
Flow Rate: 4 mL/min | ||||||||||||
Temperature: 22°C | ||||||||||||
Detection: UV-Vis Abs.-Diode Array (PDA) @ 254 nm (22°C) |
Order Items Used in This Application
CH0-7643
Onyx Monolithic C18, LC Column 100 x 4.6 mm, Ea
Qty:
Similar Applications
search
Sulfanilamide
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
